Caricamento...
Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma
Systemic therapy strategies in the setting of localized and locally advanced renal cell carcinoma (RCC) have continued to evolve in two directions: as adjuvant therapy (to reduce risk of recurrence or progression in high risk localized groups), or as neoadjuvant therapy as a strategy to render prima...
Salvato in:
| Pubblicato in: | J Oncol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Hindawi
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463563/ https://ncbi.nlm.nih.gov/pubmed/31057615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7309205 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|